Birdwatch Note
2023-02-04 11:41:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
MRNA vaccines are not gene therapy, https://apnews.com/article/fact-check-covid-vaccines-gene-therapy-806280914802 https://www.genomicseducation.hee.nhs.uk/blog/why-mrna-vaccines-arent-gene-therapies/ Covid infection doesnt have a 99.9% survival rate https://apnews.com/article/fact-checking-970830023526 https://www.vice.com/en/article/dy8kzk/do-99-percent-of-people-survive-covid-19-myths-argument https://fullfact.org/health/Covid-recovery-vaccine/
Written by E1F6BF4E8C4E25935CDF29146BF9CBD16CAFD87860A62C02B5187FB5BCF6C425
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1620026413238599680
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1621836462659452928
- noteId - 1621836462659452928
- participantId - E1F6BF4E8C4E25935CDF29146BF9CBD16CAFD87860A62C02B5187FB5BCF6C425
- noteAuthorParticipantId -
- createdAtMillis - 1675510919614
- tweetId - 1620026413238599680
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- MRNA vaccines are not gene therapy, https://apnews.com/article/fact-check-covid-vaccines-gene-therapy-806280914802 https://www.genomicseducation.hee.nhs.uk/blog/why-mrna-vaccines-arent-gene-therapies/ Covid infection doesnt have a 99.9% survival rate https://apnews.com/article/fact-checking-970830023526 https://www.vice.com/en/article/dy8kzk/do-99-percent-of-people-survive-covid-19-myths-argument https://fullfact.org/health/Covid-recovery-vaccine/
Note Ratings
rated at | rated by | |
2023-02-04 11:26:19 -0600 | 035F777F6FA85EFBF4D0E2E272229757C74F37D40D6289D253858DAF7E6119CC | Rating Details |
2023-02-04 10:42:35 -0600 | 0415710CFDD825231D330458E74370ABE9499C24330CFCC3A987ACF952D350D0 | Rating Details |
2023-02-04 10:21:14 -0600 | 0BBFE0EC283739FE7CF2AACB2CCBAB53BBA6610EE99145EE064763F6D0A9F42E | Rating Details |
2023-02-04 07:06:04 -0600 | 168DA5AE2CF160522493E2541F4A43B1D19BE7F19F314020D31800023FD7C49B | Rating Details |
2023-02-04 10:25:57 -0600 | 184E11D55E153BF6D2EDB4C341D2F02E5E3096E7113BEF1A22EB5CC0CC7CBC94 | Rating Details |
2023-02-04 11:27:08 -0600 | 1AC77089B0D43955D37C3C07CF71C50B2FF044382879E26A63D199A784FCFF58 | Rating Details |
2023-02-04 09:35:44 -0600 | 1B4E885DF78D7189AF07901DCE188F79E071934C47971AC7252A6CF6F8937565 | Rating Details |
2023-02-04 10:13:50 -0600 | 1B8BD9FAC286557D4B64A38A4103BBB31A59D2C315F74EEF2292A980CC658FE4 | Rating Details |
2023-02-04 09:24:54 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
2023-02-04 11:38:11 -0600 | 201716AB811B465F28999B5004AF601DA1740BB780C7D759F5FA00A0ED70EA48 | Rating Details |
2023-02-04 09:11:22 -0600 | 2A4169EE19A8A01657FC32ACA31E49627C4645D25E9BB4924CCFEEF066D6E9DD | Rating Details |
2023-02-04 11:46:38 -0600 | 2EBC43B631653F4C5E06EA85FAE00261343984083696E6C2C96DD6771DAF2289 | Rating Details |
2023-02-04 12:23:31 -0600 | 2F1E148E62276FF995A4480A9B87C1F2CAAFC522D4E432927F446677D1ACD5FE | Rating Details |
2023-02-04 06:48:32 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
2023-02-04 11:02:04 -0600 | 37EDDD699FC335BD573B8E361DDF5AD887EBBF76B407D94F652F11719836C294 | Rating Details |
2023-02-04 11:17:19 -0600 | 3E1663C95C5186220B99DC41829972C0318B4394E0DAEF4DCD846FA00C32AA56 | Rating Details |
2023-02-04 12:42:59 -0600 | 41F74FC0210DEB7A5579EF699B8BFD556A422A575550714C424B43D45F9BCC5E | Rating Details |
2023-02-04 19:07:22 -0600 | 45A5C3692DBA5807D688EA69497289FA0F2958102897BFD424986E4830D4EC79 | Rating Details |
2023-02-04 08:02:44 -0600 | 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 | Rating Details |
2023-02-04 12:04:39 -0600 | 4699E91C1D5A8DD4E2C63A6B2D38BBD4D7D0E96CA226E3B6F79DB7663F7DAD3F | Rating Details |
2023-02-04 11:47:16 -0600 | 4A08A16EDFA31E6D7BD170AEC8253C9D43F3C0037AEE1AD46D0D9429C506C92C | Rating Details |
2023-02-04 12:29:16 -0600 | 4FD1DC9716743D1D79ADDD1EA9974DED954A4951192A3FEAB485E354C3989CEA | Rating Details |
2023-02-04 08:26:47 -0600 | 55DD8845CB36D4A3C8FF939830B75C3B46088E7B5C2E475F714CFB4866CD4249 | Rating Details |
2023-02-04 09:45:08 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
2023-02-04 10:07:17 -0600 | 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C | Rating Details |
2023-02-04 06:24:50 -0600 | 74C1641B0692174A46A4DB704290BCBF96132765CE28D582BD3C7E5BD38C296D | Rating Details |
2023-02-04 12:06:46 -0600 | 7587F5B33DD8E4C45A2E4C461E5F5B0A54079B0BF91FE7259A82DB5054CF0D6C | Rating Details |
2023-02-04 12:14:17 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2023-02-04 10:21:24 -0600 | 805341F2454AAE7F01B4D57DC54C7C39FA36B5E1EF7FA7ED70F33F84C6C471C2 | Rating Details |
2023-02-04 10:08:05 -0600 | 8066DD9625E2999A6130F176AEC89287DA2236DFE7B6961A23E76E54DB653B26 | Rating Details |
2023-02-04 12:04:28 -0600 | 8EEB74836816E3149B6EA4E6F39D736189B150426AF4DDD0CFCC0BFF0B081BBF | Rating Details |
2023-02-04 09:04:24 -0600 | 91ED1050C69AB445CFA549CAAF55F48AAC56D267EAADDF024A57D453A99233C4 | Rating Details |
2023-02-04 11:26:48 -0600 | 983039B3AE04269183DE6E9D3C95574FB4EF5B7B12064E5C2B3929509F3ABF29 | Rating Details |
2023-02-04 10:23:02 -0600 | 99456A4BE982F568A625EC899EE37800DF4EE67A1BFD9E73819C9057DF2CD020 | Rating Details |
2023-02-04 10:21:18 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2023-02-04 12:17:01 -0600 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
2023-02-04 11:08:55 -0600 | B306D9A1BF16D3A946AACC02B226607C1E62B3960ED3E0CA076C690BF2C3446C | Rating Details |
2023-02-04 10:59:04 -0600 | BC77183811F726C0E10C88DE43023E3CBADF7F278244BADFA014B0B01187303C | Rating Details |
2023-02-04 09:55:24 -0600 | C1F9517DCA05B06E1B9531CB46CC1126B8712B511B978302F6BFA575B98AA1A2 | Rating Details |
2023-02-04 09:02:08 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
2023-02-04 12:11:47 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
2023-02-04 09:50:39 -0600 | CCCAB7C18475D95472D35284E07DD48657E29FDB27903231160570AD431045AA | Rating Details |
2023-02-04 11:32:08 -0600 | CE5C3CF79F78C5672AA0048EABEA38383B9BA5B4056FD6A65A6FF4D2E2F1FDE2 | Rating Details |
2023-02-04 11:15:44 -0600 | D2370CD7702DF2E3C2FE7E05433B476F0E8995FBD23C8D1E9AD5E061E5AAFB92 | Rating Details |
2023-02-04 11:06:26 -0600 | D35D8B590059E4DC1262E96BA4FC6B54875D1877F594F8C9F7AE213E670D5545 | Rating Details |
2023-02-04 10:19:52 -0600 | D48CFC3C90EF5D2151C7BE0E045D6075365E6DA2059DEBCD363890FC2A0A37F4 | Rating Details |
2023-02-04 10:29:01 -0600 | EE8960C16CB7C7022DD1730476EB628EC4227CF7853870765171DDEC71B603C9 | Rating Details |
2023-02-04 07:33:44 -0600 | F810B9A117A15B206340CC72B29D65263DC4B812622393BFCBE22D0EE5EE3DFF | Rating Details |
2023-02-04 12:11:47 -0600 | Rating Details | |
2023-02-04 06:24:50 -0600 | Rating Details | |
2023-02-04 19:07:22 -0600 | Rating Details | |
2023-02-04 09:04:24 -0600 | Rating Details | |
2023-02-04 09:24:54 -0600 | Rating Details | |
2023-02-04 12:04:28 -0600 | Rating Details | |
2023-02-04 07:06:04 -0600 | Rating Details | |
2023-02-04 11:27:08 -0600 | Rating Details | |
2023-02-04 09:11:22 -0600 | Rating Details | |
2023-02-04 11:46:38 -0600 | Rating Details | |
2023-02-04 12:17:01 -0600 | Rating Details | |
2023-02-04 12:04:39 -0600 | Rating Details | |
2023-02-04 12:06:46 -0600 | Rating Details | |
2023-02-04 11:32:08 -0600 | Rating Details | |
2023-02-04 09:02:08 -0600 | Rating Details | |
2023-02-04 10:42:35 -0600 | Rating Details | |
2023-02-04 10:19:52 -0600 | Rating Details | |
2023-02-04 11:02:04 -0600 | Rating Details | |
2023-02-04 11:26:19 -0600 | Rating Details | |
2023-02-04 10:21:14 -0600 | Rating Details | |
2023-02-04 12:23:31 -0600 | Rating Details | |
2023-02-04 08:26:47 -0600 | Rating Details | |
2023-02-04 10:59:04 -0600 | Rating Details | |
2023-02-04 11:26:48 -0600 | Rating Details | |
2023-02-04 09:55:24 -0600 | Rating Details | |
2023-02-04 10:23:02 -0600 | Rating Details | |
2023-02-04 10:25:57 -0600 | Rating Details | |
2023-02-04 11:08:55 -0600 | Rating Details | |
2023-02-04 12:29:16 -0600 | Rating Details | |
2023-02-04 12:14:17 -0600 | Rating Details | |
2023-02-04 11:38:11 -0600 | Rating Details | |
2023-02-04 10:21:18 -0600 | Rating Details | |
2023-02-04 10:07:17 -0600 | Rating Details | |
2023-02-04 11:47:16 -0600 | Rating Details | |
2023-02-04 06:48:32 -0600 | Rating Details | |
2023-02-04 08:02:44 -0600 | Rating Details | |
2023-02-04 07:33:44 -0600 | Rating Details | |
2023-02-04 12:42:59 -0600 | Rating Details | |
2023-02-04 11:06:26 -0600 | Rating Details | |
2023-02-04 11:17:19 -0600 | Rating Details | |
2023-02-04 10:13:50 -0600 | Rating Details | |
2023-02-04 10:29:01 -0600 | Rating Details | |
2023-02-04 11:15:44 -0600 | Rating Details | |
2023-02-04 09:50:39 -0600 | Rating Details | |
2023-02-04 10:08:05 -0600 | Rating Details | |
2023-02-04 10:21:24 -0600 | Rating Details | |
2023-02-04 09:35:44 -0600 | Rating Details |